This involves feeding animals a HFD to induce hyperinsulinemia and insulin resistance, followed by an injection of a low dose of STZ to slowly reduce pancreatic β cell mass, leading to a decrease in insulin production and mimicking the pathophysiology associated with T2DM in human (152). The gene discussed is INS; the disease is Insulin resistance.